N. AK, "THE ROLE ADJUVANT CHEMOTHERAPY IN RESECTED STAGE 1 NSCLC WITH HIGH RISK FACTORS: A TURKISH ONCOLOGY GROUP STUDY," World Conferrence of Lung Cancer 2019 , Barcelona, Spain, pp.933-934, 2019
AK, N. 2019. THE ROLE ADJUVANT CHEMOTHERAPY IN RESECTED STAGE 1 NSCLC WITH HIGH RISK FACTORS: A TURKISH ONCOLOGY GROUP STUDY. World Conferrence of Lung Cancer 2019 , (Barcelona, Spain), 933-934.
AK, N., (2019). THE ROLE ADJUVANT CHEMOTHERAPY IN RESECTED STAGE 1 NSCLC WITH HIGH RISK FACTORS: A TURKISH ONCOLOGY GROUP STUDY . World Conferrence of Lung Cancer 2019 (pp.933-934). Barcelona, Spain
AK, Naziye. "THE ROLE ADJUVANT CHEMOTHERAPY IN RESECTED STAGE 1 NSCLC WITH HIGH RISK FACTORS: A TURKISH ONCOLOGY GROUP STUDY," World Conferrence of Lung Cancer 2019, Barcelona, Spain, 2019
AK, Naziye. "THE ROLE ADJUVANT CHEMOTHERAPY IN RESECTED STAGE 1 NSCLC WITH HIGH RISK FACTORS: A TURKISH ONCOLOGY GROUP STUDY." World Conferrence of Lung Cancer 2019 , Barcelona, Spain, pp.933-934, 2019
AK, N. (2019) . "THE ROLE ADJUVANT CHEMOTHERAPY IN RESECTED STAGE 1 NSCLC WITH HIGH RISK FACTORS: A TURKISH ONCOLOGY GROUP STUDY." World Conferrence of Lung Cancer 2019 , Barcelona, Spain, pp.933-934.
@conferencepaper{conferencepaper, author={Naziye AK}, title={THE ROLE ADJUVANT CHEMOTHERAPY IN RESECTED STAGE 1 NSCLC WITH HIGH RISK FACTORS: A TURKISH ONCOLOGY GROUP STUDY}, congress name={World Conferrence of Lung Cancer 2019}, city={Barcelona}, country={Spain}, year={2019}, pages={933-934} }